600064 南京高科
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入2,399,70158.11%1,980,2574,733,0384,490,0614,934,527
减:营业总成本2,288,58454.99%1,982,3134,564,9614,095,9564,688,834
    其中:营业成本1,819,99752.66%1,543,1954,143,8663,649,0473,797,987
               财务费用143,588-11.57%209,022220,384177,024203,312
               资产减值损失----(773,775)(608,242)(2,743)(72,938)
公允价值变动收益69,518-51.44%24,779(140,770)(242,623)(34,410)
投资收益1,883,9819.25%2,293,6151,964,6752,405,3342,367,123
    其中:对联营企业和合营企业的投资收益1,780,8624.24%2,129,4471,829,7262,096,3341,686,458
营业利润2,053,3738.20%1,504,9841,367,5402,650,4142,679,073
利润总额2,521,30732.90%1,507,9231,369,9622,651,6352,679,209
减:所得税费用58,66733.25%(133,472)(112,586)171,739276,924
净利润2,462,64032.89%1,641,3951,482,5492,479,8952,402,285
减:非控股权益24,44163.87%(83,835)(77,597)77,52250,232
股东净利润2,438,19832.64%1,725,2301,560,1462,402,3742,352,053

市场价值指针
每股收益 (元) *1.40932.67%0.9970.9021.3881.359
每股派息 (元) *----0.3000.2800.4200.600
每股净资产 (元) *11.3803.60%10.86910.1369.572--
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容